SEIDENBERG BETH C enters LATIGO BIOTHERAPEUTICS, INC. with 504.36K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 429.55K | Indirect |
| Common Stock | 27.96K | Indirect |
| Common Stock | 46.85K | Indirect |
| Total | 504.36K | 504.36K indirect |
Series A-2 Convertible Preferred Stock
IndirectUnderlying shares
3.46M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A-2 Convertible Preferred Stock
IndirectUnderlying shares
1.03M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Convertible Preferred Stock
IndirectUnderlying shares
3.55M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Convertible Promissory Note
IndirectUnderlying shares
165.52K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series Seed Convertible Preferred Stock
IndirectUnderlying shares
938.98K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B Convertible Preferred Stock
IndirectUnderlying shares
1.48M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A-2 Convertible Preferred Stock
IndirectUnderlying shares
2.07M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
12.70M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A-2 Convertible Preferred Stock Indirect | Common Stock | — | — | 3.46M | N/A | |
| Series A-2 Convertible Preferred Stock Indirect | Common Stock | — | — | 1.03M | N/A | |
| Series A Convertible Preferred Stock Indirect | Common Stock | — | — | 3.55M | N/A | |
| Convertible Promissory Note Indirect | Common Stock | — | — | 165.52K | N/A | |
| Series Seed Convertible Preferred Stock Indirect | Common Stock | — | — | 938.98K | N/A | |
| Series B Convertible Preferred Stock Indirect | Common Stock | — | — | 1.48M | N/A | |
| Series A-2 Convertible Preferred Stock Indirect | Common Stock | — | — | 2.07M | N/A | |
| Total | 12.70M | 0.00 | ||||